103 related articles for article (PubMed ID: 12148889)
1. The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment.
Rasmussen T; Jensen L; Johnsen HE
Leuk Lymphoma; 2002 May; 43(5):1075-7. PubMed ID: 12148889
[TBL] [Abstract][Full Text] [Related]
2. High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma.
Rasmussen T; Kastrup J; Knudsen LM; Johnsen HE
Br J Haematol; 1999 Apr; 105(1):265-7. PubMed ID: 10233390
[TBL] [Abstract][Full Text] [Related]
3. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
[TBL] [Abstract][Full Text] [Related]
4. The clonal hierachy in multiple myeloma.
Rasmussen T; Jensen L; Johnsen HE
Acta Oncol; 2000; 39(7):765-70. PubMed ID: 11145430
[TBL] [Abstract][Full Text] [Related]
5. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements.
Szczepek AJ; Bergsagel PL; Axelsson L; Brown CB; Belch AR; Pilarski LM
Blood; 1997 Mar; 89(5):1824-33. PubMed ID: 9057669
[TBL] [Abstract][Full Text] [Related]
6. The presence of circulating clonal CD19+ cells in multiple myeloma.
Rasmussen T
Leuk Lymphoma; 2001; 42(6):1359-66. PubMed ID: 11911420
[TBL] [Abstract][Full Text] [Related]
7. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
[TBL] [Abstract][Full Text] [Related]
8. Frequency and kinetics of polyclonal and clonal B cells in the peripheral blood of patients being treated for multiple myeloma.
Rasmussen T; Jensen L; Honoré L; Johnsen HE
Blood; 2000 Dec; 96(13):4357-9. PubMed ID: 11110713
[TBL] [Abstract][Full Text] [Related]
9. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
11. Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial.
Kay NE; Leong T; Kyle RA; Greipp P; Billadeau D; Van Ness B; Bone N; Oken MM
Blood; 1997 Jul; 90(1):340-5. PubMed ID: 9207470
[TBL] [Abstract][Full Text] [Related]
12. Clonal identities and multiple isotype transcripts in hematological diseases revealed by a single-strand conformation polymorphism analysis of the immunoglobulin heavy chain messenger signals.
Shiokawa S; Nishimura J; Uike N; Saburi Y; Suehiro T; Yamamoto K
Am J Hematol; 1999 Oct; 62(2):74-81. PubMed ID: 10509000
[TBL] [Abstract][Full Text] [Related]
13. Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridization.
Joshua DE; Brown RD; Luo XF; Gibson J
Blood; 1996 Aug; 88(3):1125. PubMed ID: 8704226
[No Abstract] [Full Text] [Related]
14. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
Kara IO; Duman BB; Afsar CU
J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
[TBL] [Abstract][Full Text] [Related]
16. [Multiple myeloma stem cell].
Hosen N
Nihon Rinsho; 2015 Jan; 73(1):47-51. PubMed ID: 25626303
[TBL] [Abstract][Full Text] [Related]
17. Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays.
Rasmussen T; Jensen L; Honoré L; Andersen H; Johnsen HE
Br J Haematol; 1999 Dec; 107(4):818-24. PubMed ID: 10606890
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of immunoglobulin genes in multiple myeloma.
Kosmas C; Stamatopoulos K; Stavroyianni N; Belessi C; Viniou N; Yataganas X
Leuk Lymphoma; 1999 Apr; 33(3-4):253-65. PubMed ID: 10221505
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
20. Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation.
Rottenburger C; Kiel K; Bösing T; Cremer FW; Moldenhauer G; Ho AD; Goldschmidt H; Moos M
Br J Haematol; 1999 Aug; 106(2):545-52. PubMed ID: 10460621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
